MCG researchers address ARDS-related vascular issues
Vascular biologists in MCG have spent years developing treatments for acute respiratory distress syndrome from pneumococcal pneumonia.
FOCUS
As the COVID-19 pandemic transitions and public health conditions and treatments improve, Augusta University will begin treating COVID-19 like any other infectious disease cases.
If viral conditions change substantially, we will be ready to adapt to keep our community safe. We constantly monitor local, national, and global viral conditions and will change our policies if necessary.
Reach out to Student Health Services at 706-721-3448 with questions and for further COVID guidance while attending AU.
On the Frontlines
Vascular biologists in MCG have spent years developing treatments for acute respiratory distress syndrome from pneumococcal pneumonia.
Keel, who is vaccinated and boosted, will return to campus as soon as he has completed the isolation and return-to-work protocols defined by the CDC.
The University System of Georgia has recently updated its guidance about wearing masks on campus transportation.
“I try to live by the motto I’ve never asked somebody else to do a job that I’m not willing to do myself,” said Dr. Phillip Coule.